Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.

Emily A BurgerErik El JansenJames KillenInge McM de KokMegan A SmithStephen SyNiels DunnewindNicole G CamposJennifer S HaasSarah KobrinAruna KamineniKaren CanfellJane J Kim

Published in: Journal of medical screening (2021)

Women in need of surveillance, colposcopies, or excisional treatment, or whose last primary screen did not involve human papillomavirus testing, may comprise priority groups for reintroductions.

Keyphrases

cervical cancer screening
coronavirus disease
sars cov
healthcare
public health
palliative care
polycystic ovary syndrome
high throughput
quality improvement
type diabetes
metabolic syndrome
pain management
pregnancy outcomes
insulin resistance
skeletal muscle
pregnant women
drug induced